Melanoma: The Milan Melanoma Cell Lines

[1]  S. Aamdal,et al.  Correlation of DNA ploidy and S‐phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma , 1996, International journal of cancer.

[2]  A. Anichini,et al.  Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma. , 1996, Journal of immunology.

[3]  M. Herlyn,et al.  Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. , 1995, Cancer research.

[4]  E. Dejana,et al.  Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. , 1995, Cancer research.

[5]  A. Anichini,et al.  Expression of Interleukin 1α, Interleukin 6, and Tumor Necrosis Factor α Genes in Human Melanoma Clones Is Associated with That of Mutated N-RAS Oncogene , 1994 .

[6]  M. Herlyn,et al.  Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes , 1994, International journal of cancer.

[7]  A. Anichini,et al.  N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanoma , 1994, Melanoma research.

[8]  M. Herlyn,et al.  Melanoma cells and normal melanocytes share antigens recognized by HLA- A2-restricted cytotoxic T cell clones from melanoma patients , 1993, The Journal of experimental medicine.

[9]  S. Bernasconi,et al.  Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma. , 1992, The American journal of pathology.

[10]  A. Mantovani,et al.  Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: Role of ICAM‐1 defined by antibody blocking and gene transfer , 1992, European journal of immunology.

[11]  A. Santoni,et al.  Role of the α5β1 Integrin Receptor in the Proliferative Response of Quiescent Human Melanoma Cells to Fibronectin , 1992 .

[12]  A. Mantovani,et al.  Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. , 1991, Cancer research.

[13]  A. Anichini,et al.  Cytokine‐mediated modulation of HLA‐class II, ICAM‐1, LFA‐3 and tumor‐associated antigen profile of melanoma cells. comparison with anti‐proliferative activity by RIL1‐β, RTNF‐α, RIFN‐γ, RIl4 and their combinations , 1990 .

[14]  A. Anichini,et al.  Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones , 1986, The Journal of experimental medicine.

[15]  A. Anichini,et al.  Clonal analysis of cytotoxic T‐lymphocyte response to autologous human metastatic melanoma , 1985, International journal of cancer.

[16]  G. Sozzi,et al.  Chromosome abnormalities and fragile sites in human melanoma. , 1990, Cancer genetics and cytogenetics.

[17]  G. Parmiani,et al.  Tumorigenicity and dissemination of primary and metastatic human melanomas implanted into different sites in athymic nude mice. , 1988, Invasion & metastasis.